Literature DB >> 12700230

Kinetic instability of p53 core domain mutants: implications for rescue by small molecules.

Assaf Friedler1, Dmitry B Veprintsev, Lars O Hansson, Alan R Fersht.   

Abstract

Oncogenic mutations in the tumor suppressor protein p53 are found mainly in its DNA-binding core domain. Many of these mutants are thermodynamically unstable at body temperature. Here we show that these mutants also denature within minutes at 37 degrees C. The half-life (t(1/2)) of the unfolding of wild-type p53 core domain was 9 min. Hot spot mutants denatured more rapidly with increasing thermodynamic instability. The highly destabilized mutant I195T had a t(1/2) of less than 1 min. The wild-type p53-(94-360) construct, containing the core and tetramerization domains, was more stable, with t(1/2) = 37 min at 37 degrees C, similar to full-length p53. After unfolding, the denatured proteins aggregated, the rate increasing with higher concentrations of protein. A derivative of the p53-stabilizing peptide CDB3 significantly slowed down the unfolding rate of the p53 core domain. Drugs such as CDB3, which rescue the conformation of unstable mutants of p53, have to act during or immediately after biosynthesis. They should maintain the mutant protein in a folded conformation and prevent its aggregation, allowing it enough time to reach the nucleus and bind its sequence-specific target DNA or the p53 binding proteins that will stabilize it.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700230     DOI: 10.1074/jbc.M302458200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Reversible aggregation plays a crucial role on the folding landscape of p53 core domain.

Authors:  Daniella Ishimaru; Luis M T R Lima; Lenize F Maia; Priscila M Lopez; Ana P Ano Bom; Ana P Valente; Jerson L Silva
Journal:  Biophys J       Date:  2004-08-06       Impact factor: 4.033

2.  Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.

Authors:  Ricardo E Perez; Chad D Knights; Geetaram Sahu; Jason Catania; Vamsi K Kolukula; Daniel Stoler; Adolf Graessmann; Vasily Ogryzko; Michael Pishvaian; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.

Authors:  James S Butler; Stewart N Loh
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

4.  Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding.

Authors:  Joel L Kaar; Nicolas Basse; Andreas C Joerger; Elaine Stephens; Trevor J Rutherford; Alan R Fersht
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

5.  Effects of stability on the biological function of p53.

Authors:  Kian Hoe Khoo; Sebastian Mayer; Alan R Fersht
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

Review 6.  Structural and functional constraints in the evolution of protein families.

Authors:  Catherine L Worth; Sungsam Gong; Tom L Blundell
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-16       Impact factor: 94.444

7.  Meet me halfway: when genomics meets structural bioinformatics.

Authors:  Sungsam Gong; Catherine L Worth; Tammy M K Cheng; Tom L Blundell
Journal:  J Cardiovasc Transl Res       Date:  2011-02-25       Impact factor: 4.132

8.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

9.  Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.

Authors:  Rainer Wilcken; GuoZhen Wang; Frank M Boeckler; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

10.  Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide.

Authors:  Natalia Issaeva; Assaf Friedler; Przemyslaw Bozko; Klas G Wiman; Alan R Fersht; Galina Selivanova
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.